期刊文献+

THG的测定及反兴奋剂措施分析(1)

Apocalypse from THG Determination and Anti-doping Measures Analysis
下载PDF
导出
摘要 通过文献资料法和理论分析法,分析THG(tetrahydrogestrinone)逃脱药检的原因,探讨反运动兴奋剂措施的完善。认为在反运动兴奋剂的措施中,应加强关键性检测步骤的保密,引进更准确的基于受体结合原理的生物芯片检测技术,进一步提高初筛同化激素类药物的灵敏度;应该把那些在试验中证明具有雄性激素作用、促进合成代谢作用的没有投放市场的类固醇药物列入世界反兴奋剂条例禁用物质清单。 Objective: Search for the reasons of THG escaping from doping control tests, lind measures for anti-doping. Methods: literature review and theoretical analysis. Conclusion: Measures for sports doping control like keep secret the critical detecting steps, introduce new chips based on the pharmacological theory of receptor-ligand binding, increase sensibility of preliminary screening anabolic steroid medicine should be introduced. The steroid improved to have anabolic/androgenic activity and never commercially marketed should be named on the list of compounds banned*
作者 袁飚
出处 《南京体育学院学报(自然科学版)》 2007年第2期11-13,18,共4页 Joournal of Nanjing Institute of Physical Education:Natural Science
关键词 THG(tetrahydrogestrinone) 运动兴奋剂 类固醇 THG ( tetrahydrogestrinone ) doping steroid
  • 相关文献

参考文献3

二级参考文献9

  • 1WHO RHR. Selected practice recommendations for contraceptive use 2002 World Health Organiation. Improving access to quality care in family planning. Medical eligibility criteria for contraceptiv use. 2nd ed. 2000 World Health Organization.
  • 2WHO. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive urn. 3rd ed. [ 2004 - 04 - 02 ].http: www. WHO. Int/reproductive-health/publications/MEC-3/change-tables. html.
  • 3WHO RHR. Contraceptive implants come of age. Prog Reprod Health Res, 2003,61 ~ 1.
  • 4Sivin I, Croxatto H, Bahamondes L, et al. Two-year perfomaance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women. Contraception,2004,69(2) : 137-143.
  • 5Dieben TO,Roumen FJ,Apter D. Efficacy,cycle control,and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol, 2002,100 (3) : 585-591.
  • 6Audet MC, Moreau M, Koltum WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptivepatch vs. an oral contraceptive: a randomized controlled trial. JAMA, 2001,285(18) :2347-2351.
  • 7Loose-Mitchell DS, Stancel GM. Estrogens and progestins in Goodman and Gilman's. The Pharmacolgical Basis of Therapeutic, 2002. 1579.
  • 8Edwarcks KG, Cohen J. Reproductive choice in 2002 : the relative safety of current oral contraceptives. Hum Reprod Experts, 2000,1:1.
  • 9WHO. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use. 2nd ed. 2000 World Health Organization.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部